Steven M. Chaouki - 14 Mar 2024 Form 4 Insider Report for MAIA Biotechnology, Inc. (MAIA)

Role: Director
Signature: /s/ Steven M. Chaouki
Issuer symbol: MAIA
Transactions as of: 14 Mar 2024
Net transactions value: +$85,563
Form type: 4
Filing time: 18 Mar 2024, 17:34:31 UTC
Previous filing: 06 Mar 2024
Next filing: 02 Apr 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MAIA	Common Stock	Purchase	$40,530	+34,641	+64%	$1.17	88,891	14 Mar 2024	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	MAIA	Warrants	Purchase	$45,033	+34,641		$1.30	34,641	14 Mar 2024	Common Stock	34,641	$1.30	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The warrants were purchased pursuant to a Securities Purchase Agreement dated March 11, 2024 and were deemed options issued under the Issuer's 2021 Equity Incentive Plan on March 14, 2024. The options are exercisable beginning on the six month anniverary of the issuance date and expire 5-years after the initial exercise date.